Lecture 5 - Alkylating Agents and Platinum Compounds Flashcards
Alkylating agents
drugs that generate reactive eletrophilic (electron deficient) intermediates that react with nucleophilic (electron rich) groups on DNA and proteins –> result in attachment of alkyl group to DNA and protein
major MOA involved alkylation of purine bases in DNA; guanine N7 is most common site of alkylation
Most effective anti-cancer drugs are bifunctional alkylating agents that produce
DNA intra- and interstrand linkages
cross-links inhibit DNA replication as well as transcription
not cell-cycle phase specific
Purine bases in DNA
all ring nitrogens have some reactivity, as well as the exocyclic oxygens
nucleophilicity is controlled by steric, electronic and hydrogen bonding effects
Effects of DNA alkylation
intrastrand linking between two bases on the same strand and interstrand crosslinking of two separate strands
Effects of alkylation
alkylating agents react with many nucleophiles other than DNA bases - thiols, amines, cysteine, lysine, glutathione
toxicity to cancer cells results from DNA alkylation and DNA cross-linking; DNA protein cross-links also inhibit DNA function
cells are more susceptible in late G1 and S phases of cell cycle but alkylating agents are considered non cell cycle specific
Side effects of alkylation
measurable incidence of second malignancies in long-term survivors following chemotherapy with alkylating agents
most second malignancies arise in bone marrow (leukemias)
Crosslinkers cause various types of DNA damage
prevent replication or transcription
mispairing
DNA fragmentation
Mechlorethamine
extremely reactive compound
rapidly alkylates all nucleophiles - modifies DNA, RNA, and protein
All alkylator SEs
myelosuppression, N/V, carcinogenic and teratogenic
Two strategies have been employed in mechlorethamine to reduce reactivity and increase selectivity of nitrogen mustards
- decrease nucleophilicity of nitrogen by adding aryl groups: chlorambucil, bendamustine, melphalan; this is because primary amines form aziridinium intermediates much faster, therefore they are more reactive than the ones with aromatic rings
- prodrug strategy - cyclophoshamide
Cyclophosphamide
most useful and commonly used alkylating agent
prodrug that requires hydroxylation by hepatic CYP450
the metabolite that forms is phosphoramide mustard, which cross-links DNA
metabolite is inactivated by aldehyde dehydrogenase –> elevated aldehyde dehydrogenase leads to reduced bone marrow toxicity
Cyclophosphamide SEs
mild bone marrow toxicity
hemorrhagic cystitis - acrolein is the byproduct, which is toxic to bladder mucosa
Ifosamide
has longer half life than cyclophosphamide but increased CNS toxicity
Mesna
given with cyclophosphamide to decrease toxicity in bladder (block hemorrhagic cystitis)
mesna contains a charged anionic sulfonate group so it does not penetrate cells - anion transporters in proximal tubule excrete via kidney, mesna accumulates in urine and bladder
the free thiol on mesna reacts with and inactivates acrolein metabolites in urine
Mitomycin C
aziridine containing natural product
functions as alkylating agent
myelosuppression is dose-limiting
can form bifunctional adducts (crosslinks) which make them good chemotherapies